Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2014
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| Group Versus Individual Physiotherapy for Urinary Incontinence in Aging Women | 01/20/2014 | INTERVENTIONAL | unchanged | 4,601.85 | 0 |
|---|
| Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer | 01/23/2014 | OBSERVATIONAL | unchanged | 4,598.85 | 0 |
|---|
| TAILORx Tissue Bank | 01/31/2014 | OBSERVATIONAL | unchanged | 4,590.85 | 0 |
|---|
| Discovering the Antecedents of Rheumatoid Arthritis Flare | 01/31/2014 | OBSERVATIONAL | unchanged | 4,590.85 | 0 |
|---|
| A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread | 02/06/2014 | INTERVENTIONAL | unchanged | 4,584.85 | 0 |
|---|
| Mother and Infant Home Visiting Program Evaluation | 02/24/2014 | INTERVENTIONAL | unchanged | 4,566.85 | 0 |
|---|
| The Role of Lifestyle Factors in Breast Cancer-Related Outcomes | 03/06/2014 | INTERVENTIONAL | unchanged | 4,556.85 | 0 |
|---|
| Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer | 03/17/2014 | INTERVENTIONAL | unchanged | 4,545.85 | 0 |
|---|
| Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry | 04/01/2014 | OBSERVATIONAL | unchanged | 4,530.85 | 0 |
|---|
| Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | 04/02/2014 | INTERVENTIONAL | unchanged | 4,529.85 | 0 |
|---|
| Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project | 04/03/2014 | OBSERVATIONAL | unchanged | 4,528.85 | 0 |
|---|
| A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer | 04/08/2014 | INTERVENTIONAL | unchanged | 4,523.85 | 0 |
|---|
| Cognition in Older Breast Cancer Survivors: Treatment Exposure, APOE and Smoking History | 04/24/2014 | OBSERVATIONAL | unchanged | 4,507.85 | 0 |
|---|
| HOT: HIPEC in Ovarian Cancer as Initial Treatment | 04/28/2014 | INTERVENTIONAL | unchanged | 4,503.85 | 0 |
|---|
| The Expecting Study | 04/29/2014 | INTERVENTIONAL | unchanged | 4,502.85 | 0 |
|---|
| European Active Surveillance Study of LCS12 | 05/26/2014 | OBSERVATIONAL | unchanged | 4,475.85 | 0 |
|---|
| Effectiveness of Cervical Screening in HPV Vaccinated Women | 05/29/2014 | INTERVENTIONAL | unchanged | 4,472.85 | 0 |
|---|
| Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer | 06/12/2014 | INTERVENTIONAL | unchanged | 4,458.85 | 0 |
|---|
| Sentinel Node Vs Observation After Axillary Ultra-souND | 06/19/2014 | INTERVENTIONAL | unchanged | 4,451.85 | 0 |
|---|
| Incidence of Difficult Airway and Difficult Neuraxial Placement in Obstetric Patients | 07/17/2014 | OBSERVATIONAL | unchanged | 4,423.85 | 0 |
|---|
| Functional Snack Foods With Safflower Oil and Soy in Postmenopausal Women Having Metabolic Syndrome | 07/24/2014 | INTERVENTIONAL | unchanged | 4,416.85 | 0 |
|---|
| Pazopanib Vs. Pazopanib Plus Gemcitabine | 07/30/2014 | INTERVENTIONAL | unchanged | 4,410.85 | 0 |
|---|
| Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy | 07/30/2014 | INTERVENTIONAL | unchanged | 4,410.85 | 0 |
|---|
| mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian | 08/05/2014 | INTERVENTIONAL | unchanged | 4,404.85 | 0 |
|---|
| Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients | 08/21/2014 | INTERVENTIONAL | unchanged | 4,388.85 | 0 |
|---|
| Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer | 08/27/2014 | INTERVENTIONAL | unchanged | 4,382.85 | 0 |
|---|
| Vaginal Flora for Treatment of Bacterial Vaginosis | 09/10/2014 | INTERVENTIONAL | unchanged | 4,368.85 | 0 |
|---|
| A Study to See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers | 09/12/2014 | INTERVENTIONAL | unchanged | 4,366.85 | 0 |
|---|
| Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions | 09/12/2014 | OBSERVATIONAL | unchanged | 4,366.85 | 0 |
|---|
| Energy Balance and Breast Cancer Aspects-II | 09/16/2014 | INTERVENTIONAL | unchanged | 4,362.85 | 0 |
|---|
| A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer | 09/23/2014 | INTERVENTIONAL | unchanged | 4,355.85 | 0 |
|---|
| Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer | 10/06/2014 | INTERVENTIONAL | unchanged | 4,342.85 | 0 |
|---|
| Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET | 10/10/2014 | INTERVENTIONAL | unchanged | 4,338.85 | 0 |
|---|
| Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy | 10/22/2014 | INTERVENTIONAL | unchanged | 4,326.85 | 0 |
|---|
| Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial | 10/28/2014 | INTERVENTIONAL | unchanged | 4,320.85 | 0 |
|---|
| Comparison of Regimens MPIB, CIPCEA, PCEA | 10/30/2014 | INTERVENTIONAL | unchanged | 4,318.85 | 0 |
|---|
| Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy: | 11/03/2014 | OBSERVATIONAL | unchanged | 4,314.85 | 0 |
|---|
| [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer | 11/06/2014 | INTERVENTIONAL | unchanged | 4,311.85 | 0 |
|---|
| Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer | 11/06/2014 | INTERVENTIONAL | unchanged | 4,311.85 | 0 |
|---|
| DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics | 11/11/2014 | OBSERVATIONAL | unchanged | 4,306.85 | 0 |
|---|
| TARGIT-C(Consolidation) Prospective Phase IV Study of IORT in Patients With Small Breast Cancer | 11/14/2014 | INTERVENTIONAL | unchanged | 4,303.85 | 0 |
|---|
| Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer | 11/14/2014 | INTERVENTIONAL | unchanged | 4,303.85 | 0 |
|---|
| Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention | 11/20/2014 | INTERVENTIONAL | unchanged | 4,297.85 | 0 |
|---|
| Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant | 11/21/2014 | INTERVENTIONAL | unchanged | 4,296.85 | 0 |
|---|
| MRI Assessment of Placental Health | 11/21/2014 | OBSERVATIONAL | unchanged | 4,296.85 | 0 |
|---|
| Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease | 11/26/2014 | INTERVENTIONAL | unchanged | 4,291.85 | 0 |
|---|
| MRI Background Parenchymal Enhancement as a Risk Factor for Breast Cancer: The IMAGINg and Epidemiology (IMAGINE) Study | 11/26/2014 | OBSERVATIONAL | unchanged | 4,291.85 | 0 |
|---|
| Evaluation of Myocardial Changes During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity Earlier With MRI | 12/03/2014 | OBSERVATIONAL | unchanged | 4,284.85 | 0 |
|---|
| Sickle Cell Hemoglobinopathies and Bone Health | 12/03/2014 | OBSERVATIONAL | unchanged | 4,284.85 | 0 |
|---|
| Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer | 12/04/2014 | INTERVENTIONAL | unchanged | 4,283.85 | 0 |
|---|
| Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer | 12/09/2014 | INTERVENTIONAL | unchanged | 4,278.85 | 0 |
|---|
| Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer | 12/11/2014 | INTERVENTIONAL | unchanged | 4,276.85 | 0 |
|---|
| Analysis of Prognostic Cell Signaling Factors in Adolescent Idiopathic Scoliosis | 12/12/2014 | OBSERVATIONAL | unchanged | 4,275.85 | 0 |
|---|
| Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery | 12/12/2014 | INTERVENTIONAL | unchanged | 4,275.85 | 0 |
|---|
| Ice Versus EMLA for Pain in Laser Hair Removal | 12/17/2014 | INTERVENTIONAL | unchanged | 4,270.85 | 0 |
|---|
| Study of Placental Function in Healthy and Pathological Pregnancies | 12/19/2014 | OBSERVATIONAL | unchanged | 4,268.85 | 0 |
|---|
| Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers | 12/22/2014 | INTERVENTIONAL | unchanged | 4,265.85 | 0 |
|---|
| Tc99m Sestamibi Molecular Breast Imaging | 12/24/2014 | INTERVENTIONAL | unchanged | 4,263.85 | 0 |
|---|
| Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia | 12/31/2014 | INTERVENTIONAL | unchanged | 4,256.85 | 0 |
|---|